期刊文献+

艾恒 被引量:5

下载PDF
导出
作者 卢海儒
机构地区 青海省人民医院
出处 《中国新药杂志》 CAS CSCD 北大核心 2002年第8期653-654,共2页 Chinese Journal of New Drugs
  • 相关文献

参考文献6

二级参考文献14

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2孙燕,临床肿瘤内科手术 第3版(第3版),1996年,33-101,214-215页
  • 3De Gramont A,Vignoud J,Toumigandc,et al.Oxaliplatin with high-dose leucovor in and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.Eur J Cancer1997;33:214~219
  • 4Yrves B,Philippe R.Clinical efficacy of oxaliplatin monotherapy:phase Ⅱ trials advanced colorectal cancer.Semin Oncol 1998;25(Sup5):22~31
  • 5Duereux M,Louvet C,Bekradda M,et al.Oxaliplatin for the treatment of advanced colorecer:future directions.Semin Oncol1998; 25 (Sup5):47 ~ 537
  • 6Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatin:Mechanism of action and antineoplastic activity.Semin Oncol1998;25(Sup5):4~ 12
  • 7Bleiberg H. Role of chemotherapy for advancde colorectal cancer:New opportunities. Semin Onool,1996,23:42-50.
  • 8Extra JM, Espie M, Calvo F, et al.Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol, 1990,25:299-303.
  • 9Lynch HT, Smyrk T, Lynch JF, et al. Advanced colorectal cancer meta-analysis of 5-Fu and leucovorin in patients with advanced colorectal cancer.Ann Oncol,1992,3:205-208.
  • 10De Gramont , Vignoud J, Tournigand C, et al. Oxaliplatin with high- dose leucovorin and 5 - flurouracil 48 - hour continuous infusion in pretreated netastatic cokorectal cancer .Eur J Cancer, 1997, 33:214-219.

共引文献456

同被引文献34

  • 1张燕,左国庆,汤为学.奥沙利铂对人肝癌细胞株HepG2体外增殖的影响[J].中华肝脏病杂志,2004,12(6):374-375. 被引量:40
  • 2秦叔逵,曹梦苒,钱军,华海清,王琳,何泽明.奥沙利铂为主的FOLFOX方案治疗晚期原发性肝癌[J].临床肿瘤学杂志,2005,10(1):58-60. 被引量:77
  • 3何松,左国庆,张燕,汤为学.奥沙利铂抗人肝癌细胞株QGY增殖及其机制的研究[J].第三军医大学学报,2005,27(12):1236-1239. 被引量:10
  • 4覃理灵,廖维甲,梅铭惠.利用MTT法检测肝癌化疗药物的敏感性[J].华夏医学,2007,20(1):39-40. 被引量:13
  • 5Louvet C,Andre T,Tigaud JM,et al.Phase II study of oxaliplatin,fluo-rouracil and folinic acid in locally advanced or metastatic gastric cancer patients.J Clin Oncol,2002,20(23):4543-4548.
  • 6Artru P,Andre T,Tigaud JM,et al.Oxaliplatin(OXA),5-Fluo-rouracil,and Folinic acid(FA)in advanced metastatic gastric carcinoma(AMGC)patients:final results of a multicenter phase II study.Pro Am Soc Clin Oncol,2001,20:165.
  • 7Yeon HP,Jae LL,Beak YR,et al.Capecitabin in combination with Oxaliplatin(XELOX)as a first-line therapy for advanced gastric cancer.Cancer Chemother Pharmacol,2008,61:623-629.
  • 8Chao ying Liu,Qing Sun,Xiaosheng Hang,et al.Multicenter phase Ⅱ study of Capecitabin plus Oxaliplatin as a first-line therapy in Chinede patients with advanced gastric cancer.Anti-Cancer Drugs,2008,19:825-831.
  • 9Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma [ J ]. Lancet ,2003,362 ( 9399 ) : 1907 - 1917.
  • 10Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma:Chemoembolization improves survival [ J ]. Hepatology ,2003,37 ( 2 ) :429 - 442.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部